Human T cell lymphotropic virus type 1 infection and early neurologic development: a pilot study of 48 children

S M Montano1, J R Zunt, L Rodriguez

  • 1Instituto de Ciencias Neurológicas, Lima, Perú.

Insights

Human T cell lymphotropic virus type 1 (HTLV-1) infection was not associated with delayed neurological development in Peruvian children. Seropositive children showed no increased rates of neurodevelopmental delay compared to seronegative peers.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Viral Epidemiology

Background:

  • Human T cell lymphotropic virus type 1 (HTLV-1) is a retrovirus with global distribution.
  • HTLV-1 infection is linked to various neurological conditions, including HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
  • The impact of HTLV-1 on early neurodevelopment in children remains less understood.

Purpose of the Study:

  • To investigate the association between HTLV-1 infection and neurodevelopmental delay in a cohort of Peruvian children.
  • To compare neurodevelopmental outcomes in HTLV-1 seropositive versus seronegative children.

Main Methods:

  • A cross-sectional study involving 48 Peruvian children with known HTLV-1 exposure.
  • Serological testing for HTLV-1 antibodies was performed.
  • Neurodevelopmental status was assessed and compared between seropositive (n=10) and seronegative (n=38) children.

Main Results:

  • No statistically significant difference in the rates of neurodevelopmental delay was observed between HTLV-1 seropositive and seronegative children.
  • The prevalence of neurodevelopmental delay did not appear elevated in children infected with HTLV-1.

Conclusions:

  • HTLV-1 infection in this cohort of Peruvian children was not found to be associated with delayed neurological development.
  • Further long-term follow-up studies are warranted to fully elucidate the potential neurodevelopmental effects of pediatric HTLV-1 infection.

Related Concept Videos